Dr. Reddy's is recalling some products used to treat heartburn
Dr. Reddy's Laboratories Ltd. and its subsidiaries issued a voluntary nationwide recall of its ranitidine medicines used to treat heartburn, the US Food and Drug Administration said on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - October 24, 2019 Category: Consumer Health News Source Type: news
How Zantac went from world's best-selling drug to being pulled from store shelves
Health authorities worldwide are investigating the safety of Zantac heartburn medicine, also sold generically as ranitidine, after finding a probable cancer-causing impurity in the drug. Here is a timeline on Zantac. (Source: CBC | Health)
Source: CBC | Health - October 22, 2019 Category: Consumer Health News Tags: News/Health Source Type: news
Years of hiccups and heartburn could lead to cancer by exposing cells to stomach acid, doctors warn
Peter Denson, 66, a retired coach engineer from Kent, suffered 20 years of seemingly harmless hiccups, burping and heartburn. He was shocked to be diagnosed with oesophageal cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - October 22, 2019 Category: Consumer Health News Source Type: news
Zantac Recalled by Sanofi
MONDAY, Oct. 21, 2019 -- The over-the-counter heartburn drug Zantac (ranitidine) has been recalled in the United States and Canada by French drug maker Sanofi.
The recall comes a month after the U.S. Food and Drug Administration first warned that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 21, 2019 Category: Pharmaceuticals Source Type: news
Timeline: Popular heartburn medicine Zantac pulled off store shelves
The U.S. Food and Drug Administration and international health authorities are investigating the safety of Zantac heartburn medicine, also sold generically as ranitidine, after finding a probable cancer-causing impurity in the drug. (Source: Reuters: Health)
Source: Reuters: Health - October 21, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Heartburn drug Zantac recalled in Canada, U.S. over contamination fears
Health Canada said it was investigating the possible presence of a carcinogen in some ranitidine drugs available by prescription and over-the-counter. (Source: CBC | Health)
Source: CBC | Health - October 19, 2019 Category: Consumer Health News Tags: News/Health Source Type: news
Surgery Best Option in the Uncommon Case When PPIs Fail to Stem Heartburn Surgery Best Option in the Uncommon Case When PPIs Fail to Stem Heartburn
When heartburn is refractory to proton-pump inhibitor (PPI) treatment, antireflux surgery is a better option than reflux-reducing medication such as baclofen or treatment with neuromodulators, a new clinical trial shows.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 18, 2019 Category: Surgery Tags: Gastroenterology News Source Type: news
Over-The-Counter Heartburn Drug Zantac Recalled For Possible Contamination
(AP) — Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.
The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.
In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. The federal agency said consumers could consider taking another heartburn medicine or contact their doctor.
Several drugstore chains have already removed Zantac and generic ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 18, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News Recall Zantac Source Type: news
Over-the-counter heartburn drug Zantac pulled in US, Canada
Drugmaker Sanofi latest to recall over-the-counter heartburn drug Zantac because of possible contamination (Source: ABC News: Health)
Source: ABC News: Health - October 18, 2019 Category: Consumer Health News Tags: Health Source Type: news
Sanofi pulls Zantac from U.S. and Canada after carcinogen found
Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity. (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Zantac Recall Widens as Sanofi Pulls Its Drug Over Carcinogen Fears
The company ’s announcement follows decisions by Walgreens, CVS and others to remove the drug from their shelves and after other manufacturers recalled their products. (Source: NYT Health)
Source: NYT Health - October 18, 2019 Category: Consumer Health News Authors: Katie Thomas Tags: Sanofi SA Drugs (Pharmaceuticals) Cancer Hazardous and Toxic Substances Food and Drug Administration Recalls and Bans of Products Heartburn your-feed-healthcare Zantac United States Canada Source Type: news
Teva UK is latest pharmaceutical giant to recall batches of heartburn drug Zantac
An alert was today circulated by the British medicines watchdog on behalf of Teva UK whose product may have been contaminated with N-nitrosodimethylamine (NDMA). (Source: the Mail online | Health)
Source: the Mail online | Health - October 17, 2019 Category: Consumer Health News Source Type: news
Teva's UK arm recalls some batches of Ranitidine: Medicines watchdog
Teva Pharmaceutical's UK unit has recalled some batches of heartburn medicine Ranitidine, Britain's medicines watchdog said on Thursday, making it the latest drugmaker to pull the product. (Source: Reuters: Health)
Source: Reuters: Health - October 17, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Surgery May Be Best Option for Some With Refractory Heartburn
WEDNESDAY, Oct. 16, 2019 -- In patients who truly have proton pump inhibitor (PPI)-refractory heartburn, including those with reflux hypersensitivity, surgery may be the best treatment option, according to a study published in the Oct. 16 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2019 Category: Pharmaceuticals Source Type: news
Heartburn
Title: HeartburnCategory: Diseases and ConditionsCreated: 5/18/2011 12:00:00 AMLast Editorial Review: 10/14/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 14, 2019 Category: Nutrition Source Type: news
